Detalhe da pesquisa
1.
Optimizing the value of lenalidomide maintenance by extended genetic profiling: an analysis of 556 patients in the Myeloma XI trial.
Blood
; 141(14): 1666-1674, 2023 04 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36564045
2.
Laboratory practice is central to earlier myeloma diagnosis: Utilizing a primary care diagnostic tool and laboratory guidelines integrated into haematology services.
Br J Haematol
; 204(2): 476-486, 2024 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38168756
3.
Longitudinal dynamics and clinically available predictors of poor response to COVID-19 vaccination in multiple myeloma.
Haematologica
; 2024 Jan 25.
Artigo
Inglês
| MEDLINE | ID: mdl-38268439
4.
Determinants of durable humoral and T cell immunity in myeloma patients following COVID-19 vaccination.
Eur J Haematol
; 112(4): 547-553, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38116695
5.
Investigation and management of the monoclonal gammopathy of undetermined significance: A British Society for Haematology Good Practice Paper.
Br J Haematol
; 202(4): 734-744, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37587091
6.
Immune responses to COVID-19 booster vaccinations in intensively anti-CD38 antibody treated patients with ultra-high-risk multiple myeloma: results from the Myeloma UK (MUK) nine OPTIMUM trial.
Br J Haematol
; 201(5): 845-850, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36895158
7.
The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from 'Myeloma XI', a multicentre, open-label, randomised, phase III trial.
Br J Haematol
; 201(2): 267-279, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36541152
8.
SARS-CoV-2 infection is associated with anti-desmoglein 2 autoantibody detection.
Clin Exp Immunol
; 213(2): 243-251, 2023 07 21.
Artigo
Inglês
| MEDLINE | ID: mdl-37095599
9.
Monoclonal gammopathy of increasing significance: time to screen?
Haematologica
; 108(6): 1476-1486, 2023 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36373250
10.
Valproic acid disables the Nrf2 anti-oxidant response in acute myeloid leukaemia cells enhancing reactive oxygen species-mediated killing.
Br J Cancer
; 126(2): 275-286, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34686779
11.
Immune response to COVID-19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T-cell response.
Br J Haematol
; 197(3): 293-301, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35064676
12.
SARS-CoV-2 vaccine responses following CD20-depletion treatment in patients with haematological and rheumatological disease: a West Midlands Research Consortium study.
Clin Exp Immunol
; 207(1): 3-10, 2022 01 28.
Artigo
Inglês
| MEDLINE | ID: mdl-35020852
13.
Thrombosis in patients with myeloma treated in the Myeloma IX and Myeloma XI phase 3 randomized controlled trials.
Blood
; 136(9): 1091-1104, 2020 08 27.
Artigo
Inglês
| MEDLINE | ID: mdl-32438407
14.
Autologous stem cell transplantation is safe and effective for fit older myeloma patients: exploratory results from the Myeloma XI trial.
Haematologica
; 107(1): 231-242, 2022 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33297668
15.
Investigating the utility of saliva immunoglobulins for the detection of myeloma and using myeloma proteins to clarify partition between oral and systemic immunity.
Eur J Haematol
; 108(6): 493-502, 2022 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-35184331
16.
Development of a high-sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS-CoV-2 spike glycoprotein in serum and saliva.
Immunology
; 164(1): 135-147, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-33932228
17.
Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial.
PLoS Med
; 18(1): e1003454, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33428632
18.
Diagnostic pathways in multiple myeloma and their relationship to end organ damage: an analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) trial.
Br J Haematol
; 192(6): 997-1005, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32798327
19.
Early relapse after high-dose melphalan autologous stem cell transplant predicts inferior survival and is associated with high disease burden and genetically high-risk disease in multiple myeloma.
Br J Haematol
; 193(3): 551-555, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32524584
20.
Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma: results from Myeloma XI, a multicentre, open-label, randomised, Phase III trial.
Br J Haematol
; 192(5): 853-868, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32656799